Showing results (71-80 of 83) with videos related to
Sort By:
Pageof 9
Journal of Viral Hepatitis|February 1, 2019
Interferon-free therapy as the cause of white matter tracts and cerebral perfusion recovery in patients with chronic hepatitis CJoanna Bladowska, Tomasz Pawłowski, Katarzyna Fleischer-Stępniewska, et al.Journal of the Neurological Sciences|February 16, 2019
Evaluation of brain volume alterations in HCV-infected patients after interferon-free therapy: A pilot studyEwelina Marciniewicz, Przemysław Podgórski, Tomasz Pawłowski, et al.Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|June 4, 2021
HCV resistance-associated substitutions following direct-acting antiviral therapy failure - Real-life data from PolandMiłosz Parczewski, Ewa Janczewska, Arkadiusz Pisula, et al.Current HIV Research|January 5, 2011
Fat tissue distribution changes in HIV-infected patients treated with lopinavir/ritonavir. Results of the MONARK trialSami Kolta, Philippe Flandre, Philippe Ngo Van, et al.Plos One|February 25, 2017
Expanding HIV-1 subtype B transmission networks among men who have sex with men in PolandMiłosz Parczewski, Magdalena Leszczyszyn-Pynka, Magdalena Witak-Jędra, et al.AIDS (London, England)|October 6, 2018
Variation in antiretroviral treatment coverage and virological suppression among three HIV key populationsKamilla Grønborg Laut, Leah Shepherd, Magnus Gottfredsson, et al.HIV Medicine|December 10, 2021
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA studyAmanda Mocroft, Jose M Miro, Gilles Wandeler, et al.HIV Medicine|December 9, 2021
HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in EuropeSarah Amele, Anastasia Karachalia Sandri, Alison Rodger, et al.World Journal of Gastroenterology|March 30, 2016
Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1Ira Jacobson, Stefan Zeuzem, Robert Flisiak, et al.Journal of the International AIDS Society|November 15, 2014
Time trends in HIV-1 transmitted drug resistance mutation frequency in PolandMilosz Parczewski, Magdalena Witak-Jedra, Katarzyna Maciejewska, et al.Pageof 9